Related Experiment Videos
Left ventricular pannus causing inflow obstruction late after mitral valve replacement for endocardial fibroelastosis
S Dinarevic1, A Redington, M Rigby
1Department of Pediatric Cardiology, Royal Brompton National Heart and Lung Hospital, London, UK.
Pediatric Cardiology
|July 1, 1996
Summary
A rare complication of mitral valve replacement in a child with endocardial fibroelastosis is reported. Postmortem examination revealed severe inflow obstruction due to pannus formation around the prosthetic valve.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Cardiac Surgery
Background:
- Endocardial fibroelastosis (EFE) is a rare congenital heart disease characterized by excessive fibrous and elastic tissue in the endocardium.
- Mitral valve replacement is a treatment option for severe mitral valve disease, including that caused by EFE.
- Complications after prosthetic valve implantation can occur, necessitating careful long-term monitoring.
Observation:
- A 14-year-old boy with a history of EFE and prior mitral valve replacement presented with cardiac failure.
- Echocardiography revealed a thickened, immobile prosthetic valve causing restrictive left ventricular inflow and severely reduced ejection fraction.
- Electrocardiogram showed atrioventricular reentry tachycardia, and the patient ultimately experienced cardiac arrest and died.
Findings:
- Postmortem examination identified severe left ventricular inflow obstruction.
- This obstruction was attributed to pannus/fibrosis formation around the prosthetic mitral valve's ventricular aspect.
- This specific complication of pannus formation after mitral valve replacement in pediatric EFE has not been previously described.
Implications:
- This case highlights a novel and potentially fatal complication following mitral valve replacement in pediatric patients with EFE.
- It underscores the importance of recognizing and investigating prosthetic valve dysfunction in this patient population.
- Further research may be needed to understand the mechanisms and optimize management strategies for EFE-related valve complications.